Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Change in Receivables (2016 - 2025)

Surgery Partners (SGRY) has disclosed Change in Receivables for 12 consecutive years, with $46.1 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables rose 12.71% to $46.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $53.8 million through Dec 2025, down 25.38% year-over-year, with the annual reading at $53.8 million for FY2025, 25.38% down from the prior year.
  • Change in Receivables hit $46.1 million in Q4 2025 for Surgery Partners, up from $16.2 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $46.1 million in Q4 2025 to a low of -$8.8 million in Q1 2023.
  • Historically, Change in Receivables has averaged $12.0 million across 5 years, with a median of $13.4 million in 2021.
  • Biggest five-year swings in Change in Receivables: soared 975.0% in 2021 and later plummeted 340.0% in 2023.
  • Year by year, Change in Receivables stood at $13.7 million in 2021, then soared by 182.48% to $38.7 million in 2022, then fell by 25.06% to $29.0 million in 2023, then soared by 41.03% to $40.9 million in 2024, then grew by 12.71% to $46.1 million in 2025.
  • Business Quant data shows Change in Receivables for SGRY at $46.1 million in Q4 2025, $16.2 million in Q3 2025, and -$3.7 million in Q2 2025.